← back to search

Uwe Zimmermann

KUKA (Germany) · DE
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Renal cell carcinoma treatment, Heat shock proteins research, Prostate Cancer Treatment and Research, and Renal and related cancers.
h-index
27
citations
2,362
works
87
NIH funding
primary concept
Medicine
email

Recent publications

Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma
JAMA Oncology 2024cited by 5position: middledoi
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
The Lancet Oncology 2022cited by 166position: middledoi
SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer
European Urology 2015cited by 142position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christian Lerchenmüller · University Hospital Heidelberg1 papers (2015–2015) · 1 papers (2015–2015) · 1 papers (2015–2015) · 1 papers (2015–2015)Christian Eichelberg · McGill University Health Centre1 papers (2015–2015)Sascha Pahernik · Nuremberg Hospital1 papers (2015–2015) · 1 papers (2015–2015) · 1 papers (2015–2015)Maurice Stephan Michel · German Cancer Research Center1 papers (2015–2015)Werner Freier · University of Hildesheim1 papers (2015–2015) · 1 papers (2015–2015)Anne Flörcken · Deutschen Konsortium für Translationale Krebsforschung1 papers (2015–2015)Maria De Santis · Charité - Universitätsmedizin Berlin1 papers (2015–2015) · 1 papers (2015–2015)Kirsten Hauswald · University Hospital Frankfurt1 papers (2015–2015)Peter J. Goebell · Comprehensive Cancer Center Erlangen1 papers (2015–2015)Ludwig Fischer von Weikersthal · University Hospital Heidelberg1 papers (2015–2015)Michael Staehler · Klinik und Poliklinik für Urologie1 papers (2015–2015)Maartje Los · St. Antonius Ziekenhuis1 papers (2015–2015)